Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D03TPE
|
|||
| Drug Name |
Hydroxyqunoline analog 2
|
|||
| Synonyms |
PMID25468267-Compound-42
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C10H7NO3
|
|||
| Canonical SMILES |
C1=CC2=C(C=CN=C2C(=C1)O)C(=O)O
|
|||
| InChI |
1S/C10H7NO3/c12-8-3-1-2-6-7(10(13)14)4-5-11-9(6)8/h1-5,12H,(H,13,14)
|
|||
| InChIKey |
KPTUKANGPPVLMD-UHFFFAOYSA-N
|
|||
| CAS Number |
CAS 55698-67-4
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Lysine-specific demethylase 4E (KDM4E) | Target Info | Inhibitor | [1] |
| Target's Patent Info | Lysine-specific demethylase 4E (KDM4E) | Target's Patent Info | [1] | |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | KDM4 histone demethylase inhibitors for anti-cancer agents: a patent review.Expert Opin Ther Pat. 2015 Feb;25(2):135-44. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.